News

News Center

Once again recognized—Jiuzhitang Maker proudly earns the 2021 China Biopharmaceutical Company with Greatest Growth Potential Award.

2021-10-12

On October 11, 2021, at the special gala dinner ceremony of the 2021 Shanghai (Minhang) Biopharmaceutical Industry Innovation Summit, the winners of the 3rd Starlight List 2021—selected jointly by "MedMakers-Starlight Research Institute" and industry experts—were officially announced. Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. once again made the list, earning the prestigious "2021 China Biopharmaceutical Company with the Greatest Growth Potential Award."

Last year, Jiuzhitang Maker also won the "Top 50 Most Innovative Chinese Biopharmaceutical Companies 2020" award from the Starlight List and the "2020 Outstanding Corporate Social Responsibility Award" presented by Health News.

Since its establishment, Jiuzhitang Maker has steadily advanced, building on solid foundations and leaving a lasting legacy through relentless effort and remarkable achievements. In February 2020, Jiuzhitang Maker’s clinical trial for a new stem-cell-based drug received approval, marking three industry "firsts" in China’s stem-cell therapy sector: it was the first clinical trial approved by the CDE to use imported stem cells; the first to apply stem cells for treating major neurological conditions; and, most significantly, the first trial conducted after the National Medical Products Administration resumed accepting applications for stem-cell clinical trials—using bone-marrow-derived mesenchymal stem cells. This groundbreaking milestone holds immense significance for the development of China’s stem-cell industry. The clinical trial officially kicked off in January 2021, and patient enrollment is currently underway.

This year, we’ve once again made the list, earning the "2021 China Biopharmaceutical Company with the Greatest Growth Potential Award"—a testament to and recognition of our company’s remarkable breakthroughs and strong capabilities in the stem-cell field, as acknowledged by industry media and experts.

In the future, Jiuzhitang Maker will continue to uphold Jiu Zhitang’s over-370-year-old family motto—“A pharmacist should dedicate their utmost effort, and a physician should act with integrity”—while fully leveraging the U.S.’s robust R&D infrastructure and advanced manufacturing expertise, combined with China’s cutting-edge technological upgrades and strong industrialization capabilities. Together, this will enable more efficient collaboration of resources and technology, ultimately driving the successful launch of stem-cell-based pharmaceuticals in the domestic market.

"The 'Most Influential List in China's Pharmaceutical Industry' Officially Released—Li Zhenguo, Chairman of Jiuzhitang, Honored as One of China's Top 10 Leaders in the Pharmaceutical Sector"

Just released! Shanghai will advance breakthroughs in cutting-edge scientific challenges and key technologies related to stem cells and regenerative medicine, aiming to establish a Stem Cell Regenerative Medicine Center along with a thriving cluster of emerging technology industries.

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license